| Source: |
| Type: Protein-coding gene |
| An enzyme that in humans is encoded by the AMACR gene. AMACR is a valuable diagnostic marker because of its persistent and strong expression in case of needle biopsies. (AMACR) is a mitochondrial and peroxisomal enzyme that is overexpressed in prostate cancer(PCa). AMACR is frequently used as a biomarker in prostate cancer diagnosis. Its expression is typically elevated in malignant prostate tissues compared to benign tissues. The overexpression of AMACR is associated with the presence of cancer and can aid in differentiating between cancerous and non-cancerous prostate tissues. Other Cancers: In colorectal and breast cancers, AMACR expression has been associated with tumor progression and may serve as a prognostic marker. Elevated AMACR levels could indicate a more aggressive tumor phenotype, leading to worse survival rates. AMACR is frequently overexpressed, allowing tumor cells to: -Utilize branched-chain lipids as an energy and carbon source -Support membrane synthesis and redox balance -Thrive in nutrient-variable microenvironments -AMACR is therefore best viewed as a metabolic enabler, not a classical oncogenic driver. |
| 76- | QC, | Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): implications for nutritional transcriptomics and multi-target therapy |
| - | in-vitro, | Pca, | PC3 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:408 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid